Alemtuzumab Intravenous and Dalacin C Palmitate Oral
Determining the interaction of Alemtuzumab Intravenous and Dalacin C Palmitate Oral and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: alemtuzumab
Brand name: Campath, Lemtrada
Synonyms: Alemtuzumab
Generic Name: clindamycin
Brand name: Cleocin HCl, Cleocin Pediatric, Cleocin Phosphate, Cleocin Phosphate ADD-Vantage, Clindesse, ClindaMax Vaginal, Cleocin
Synonyms: Clindamycin, Clindamycin (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Alemtuzumab Intravenous-Dalbavancin
- Alemtuzumab Intravenous-Dalbavancin Hydrochloride
- Alemtuzumab Intravenous-Dalbavancin Injection
- Alemtuzumab Intravenous-Dalbavancin Intravenous
- Alemtuzumab Intravenous-Dalfampridine
- Alemtuzumab Intravenous-Dalfopristin and quinupristin
- Dalacin C Palmitate Oral-Alenaze-D
- Dalacin C Palmitate Oral-Alendronate
- Dalacin C Palmitate Oral-Alendronate and cholecalciferol
- Dalacin C Palmitate Oral-Alendronate Effervescent Tablets
- Dalacin C Palmitate Oral-Alendronate Oral Solution
- Dalacin C Palmitate Oral-Alendronate Sodium